Clinical Trials
29 trialsS1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
SWOG Cancer Research Network
PTNS and PFR in the Treatment of Childhood Constipation
Shengjing Hospital
S1316, Surgery or Non-Surgical Management in Treating Patients With Intra-Abdominal Cancer and Bowel Obstruction
SWOG Cancer Research Network
A Study of Special Use Results Surveillance of Revlimid 5mg Capsules
Celgene
A Safety and Efficacy Study of Revlimid® 5 mg Capsules in Patients With Relapsed or Refractory Multiple Myeloma Who Have Received Long-term Treatment With it Under the Actual Condition of Use
Celgene
DEMCON
University of Ulster
The Bowel Research Collaborative Data Tracking System Implementation Study
British Columbia Cancer Agency
A Study Comparing Oxycodone to Oxycodone/Naloxone in Moderate to Severe, Chronic Cancer Pain
Mundipharma Research GmbH & Co KG
Clinical Trial on Palliative Cancer Patients With Constipation
Hong Kong Baptist University
CLARO
Dartmouth-Hitchcock Medical Center
Changes in Patient Reported Constipation Among Advanced Cancer Patients After Receiving an Educational Intervention
M.D. Anderson Cancer Center
FOCCUS
Royal Marsden NHS Foundation Trust
FIESTA
Sheffield Children's NHS Foundation Trust
Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Managing Medication-induced Constipation in Cancer: A Clinical Trial
H. Lee Moffitt Cancer Center and Research Institute
Methylnaltrexone for Opioid-induced Constipation in Cancer Patients
University of Vermont
Study 767905/008 Extension Study: Alvimopan for Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Alvimopan For The Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Random Comparison of LigaSure and Disposable Staples for Laparoscopic Surgery
University Hospitals Cleveland Medical Center
Naloxone SR Capsules in Patients With Opioid Induced Constipation
S.L.A. Pharma AG
Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery
Northwestern University
Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction
Northwestern University
Endoscopic Placement of Metal Stent in Patients With Cancer-Related Bowel Obstruction
Northwestern University
Fiber Formula Study Among Radiation Oncology Patients
Mayo Clinic
Cross Sectional Study of Constipation in Advanced Cancer Patients
Yan Chai Hospital
Prevention of Constipation: Systematic Nursing Interventions to Reduce Postoperative Constipation After Thoracic Surgery
Rigshospitalet, Denmark
Constipation in Pediatric Cancer Patients Receiving Vinca Alkaloids or Narcotics
National Institutes of Health Clinical Center (CC)